世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4730 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（ARPKD））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・多発性嚢胞腎治療薬の市場動向 ・企業の競争状況、市場シェア ・多発性嚢胞腎治療薬の種類別市場規模と予測2016-2027（ANG-3070、CIM-2、CR-8、その他） ・多発性嚢胞腎治療薬の用途別市場規模と予測2016-2027（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（ARPKD）） ・多発性嚢胞腎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・多発性嚢胞腎治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・多発性嚢胞腎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多発性嚢胞腎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・多発性嚢胞腎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Merck、Otsuka Holdings、Reata Pharmaceuticals、Sanofi） ・結論

Market Analysis and Insights: Global Polycystic Kidney Disease Treatment Drugs Market
The global Polycystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Polycystic Kidney Disease Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Polycystic Kidney Disease Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Polycystic Kidney Disease Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Polycystic Kidney Disease Treatment Drugs market.

Global Polycystic Kidney Disease Treatment Drugs Scope and Market Size
Polycystic Kidney Disease Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polycystic Kidney Disease Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ANG-3070
CIM-2
CR-8
Others

Segment by Application
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Recessive Polycystic Kidney Disease (ARPKD)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Merck
Otsuka Holdings
Reata Pharmaceuticals
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polycystic Kidney Disease Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ANG-3070
1.2.3 CIM-2
1.2.4 CR-8
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polycystic Kidney Disease Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autosomal Dominant Polycystic Kidney Disease (ADPKD)
1.3.3 Autosomal Recessive Polycystic Kidney Disease (ARPKD)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Polycystic Kidney Disease Treatment Drugs Market Perspective (2016-2027)
2.2 Polycystic Kidney Disease Treatment Drugs Growth Trends by Regions
2.2.1 Polycystic Kidney Disease Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Polycystic Kidney Disease Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Polycystic Kidney Disease Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Polycystic Kidney Disease Treatment Drugs Industry Dynamic
2.3.1 Polycystic Kidney Disease Treatment Drugs Market Trends
2.3.2 Polycystic Kidney Disease Treatment Drugs Market Drivers
2.3.3 Polycystic Kidney Disease Treatment Drugs Market Challenges
2.3.4 Polycystic Kidney Disease Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Polycystic Kidney Disease Treatment Drugs Players by Revenue
3.1.1 Global Top Polycystic Kidney Disease Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Polycystic Kidney Disease Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Polycystic Kidney Disease Treatment Drugs Revenue
3.4 Global Polycystic Kidney Disease Treatment Drugs Market Concentration Ratio
3.4.1 Global Polycystic Kidney Disease Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polycystic Kidney Disease Treatment Drugs Revenue in 2020
3.5 Polycystic Kidney Disease Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Polycystic Kidney Disease Treatment Drugs Product Solution and Service
3.7 Date of Enter into Polycystic Kidney Disease Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Polycystic Kidney Disease Treatment Drugs Breakdown Data by Type
4.1 Global Polycystic Kidney Disease Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Polycystic Kidney Disease Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Polycystic Kidney Disease Treatment Drugs Breakdown Data by Application
5.1 Global Polycystic Kidney Disease Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Polycystic Kidney Disease Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Polycystic Kidney Disease Treatment Drugs Market Size (2016-2027)
6.2 North America Polycystic Kidney Disease Treatment Drugs Market Size by Type
6.2.1 North America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Polycystic Kidney Disease Treatment Drugs Market Size by Application
6.3.1 North America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Polycystic Kidney Disease Treatment Drugs Market Size by Country
6.4.1 North America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Polycystic Kidney Disease Treatment Drugs Market Size (2016-2027)
7.2 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Type
7.2.1 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Application
7.3.1 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Country
7.4.1 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Polycystic Kidney Disease Treatment Drugs Market Size (2016-2027)
9.2 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Type
9.2.1 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Application
9.3.1 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Country
9.4.1 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Polycystic Kidney Disease Treatment Drugs Introduction
11.2.4 Merck Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Otsuka Holdings
11.3.1 Otsuka Holdings Company Details
11.3.2 Otsuka Holdings Business Overview
11.3.3 Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Introduction
11.3.4 Otsuka Holdings Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
11.3.5 Otsuka Holdings Recent Development
11.4 Reata Pharmaceuticals
11.4.1 Reata Pharmaceuticals Company Details
11.4.2 Reata Pharmaceuticals Business Overview
11.4.3 Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Introduction
11.4.4 Reata Pharmaceuticals Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
11.4.5 Reata Pharmaceuticals Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Polycystic Kidney Disease Treatment Drugs Introduction
11.5.4 Sanofi Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
11.5.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Polycystic Kidney Disease Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ANG-3070
Table 3. Key Players of CIM-2
Table 4. Key Players of CR-8
Table 5. Key Players of Others
Table 6. Global Polycystic Kidney Disease Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Polycystic Kidney Disease Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Polycystic Kidney Disease Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Polycystic Kidney Disease Treatment Drugs Market Share by Regions (2016-2021)
Table 10. Global Polycystic Kidney Disease Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Polycystic Kidney Disease Treatment Drugs Market Share by Regions (2022-2027)
Table 12. Polycystic Kidney Disease Treatment Drugs Market Trends
Table 13. Polycystic Kidney Disease Treatment Drugs Market Drivers
Table 14. Polycystic Kidney Disease Treatment Drugs Market Challenges
Table 15. Polycystic Kidney Disease Treatment Drugs Market Restraints
Table 16. Global Polycystic Kidney Disease Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Polycystic Kidney Disease Treatment Drugs Market Share by Players (2016-2021)
Table 18. Global Top Polycystic Kidney Disease Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment Drugs as of 2020)
Table 19. Ranking of Global Top Polycystic Kidney Disease Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Polycystic Kidney Disease Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Polycystic Kidney Disease Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Polycystic Kidney Disease Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Polycystic Kidney Disease Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Polycystic Kidney Disease Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Polycystic Kidney Disease Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Polycystic Kidney Disease Treatment Drugs Product
Table 66. Johnson & Johnson Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Polycystic Kidney Disease Treatment Drugs Product
Table 71. Merck Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Otsuka Holdings Company Details
Table 74. Otsuka Holdings Business Overview
Table 75. Otsuka Holdings Polycystic Kidney Disease Treatment Drugs Product
Table 76. Otsuka Holdings Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021) & (US$ Million)
Table 77. Otsuka Holdings Recent Development
Table 78. Reata Pharmaceuticals Company Details
Table 79. Reata Pharmaceuticals Business Overview
Table 80. Reata Pharmaceuticals Polycystic Kidney Disease Treatment Drugs Product
Table 81. Reata Pharmaceuticals Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021) & (US$ Million)
Table 82. Reata Pharmaceuticals Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Polycystic Kidney Disease Treatment Drugs Product
Table 86. Sanofi Revenue in Polycystic Kidney Disease Treatment Drugs Business (2016-2021) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polycystic Kidney Disease Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. ANG-3070 Features
Figure 3. CIM-2 Features
Figure 4. CR-8 Features
Figure 5. Others Features
Figure 6. Global Polycystic Kidney Disease Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 7. Autosomal Dominant Polycystic Kidney Disease (ADPKD) Case Studies
Figure 8. Autosomal Recessive Polycystic Kidney Disease (ARPKD) Case Studies
Figure 9. Polycystic Kidney Disease Treatment Drugs Report Years Considered
Figure 10. Global Polycystic Kidney Disease Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Polycystic Kidney Disease Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Polycystic Kidney Disease Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Polycystic Kidney Disease Treatment Drugs Market Share by Regions (2022-2027)
Figure 14. Global Polycystic Kidney Disease Treatment Drugs Market Share by Players in 2020
Figure 15. Global Top Polycystic Kidney Disease Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Kidney Disease Treatment Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Polycystic Kidney Disease Treatment Drugs Revenue in 2020
Figure 17. Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Polycystic Kidney Disease Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Polycystic Kidney Disease Treatment Drugs Market Share by Type (2016-2027)
Figure 21. North America Polycystic Kidney Disease Treatment Drugs Market Share by Application (2016-2027)
Figure 22. North America Polycystic Kidney Disease Treatment Drugs Market Share by Country (2016-2027)
Figure 23. United States Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Polycystic Kidney Disease Treatment Drugs Market Share by Type (2016-2027)
Figure 27. Europe Polycystic Kidney Disease Treatment Drugs Market Share by Application (2016-2027)
Figure 28. Europe Polycystic Kidney Disease Treatment Drugs Market Share by Country (2016-2027)
Figure 29. Germany Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Polycystic Kidney Disease Treatment Drugs Market Share by Region (2016-2027)
Figure 39. China Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Polycystic Kidney Disease Treatment Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Polycystic Kidney Disease Treatment Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Polycystic Kidney Disease Treatment Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Polycystic Kidney Disease Treatment Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Polycystic Kidney Disease Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
Figure 60. Otsuka Holdings Revenue Growth Rate in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
Figure 61. Reata Pharmaceuticals Revenue Growth Rate in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Polycystic Kidney Disease Treatment Drugs Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---